Recent Reports



Evidence report on CGRP inhibitors for migraine prevention, subject to public deliberation during a meeting of CTAF.

View More on this Topic

ICER’s Draft Evidence Report on elagolix for endometriosis, open to public comment until May 31, 2018 at 5pm ET. For more information on submitting a public comment, please visit our stakeholder engagement page.

View More on this Topic

Materials

CTAF

Migraine: Evidence Presentation

Midwest CEPAC

Cystic Fibrosis: Report-at-a-Glance

Midwest CEPAC

Prostate Cancer: Model Analysis Plan

Midwest CEPAC

Cystic Fibrosis: Evidence Presentation

Orphan Drug Summit: Journal Publication

Midwest CEPAC

Cystic Fibrosis: Response to Comments

Midwest CEPAC

Prostate Cancer: Research Protocol

Midwest CEPAC

Amyloidosis: Research Protocol

Midwest CEPAC

Asthma: Public Comment on Draft Scoping Document

Midwest CEPAC

Asthma: Draft Scoping Document

Midwest CEPAC

Asthma: Stakeholder List

CTAF

Asthma: Revised Scoping Document